[
  {
    "ts": null,
    "headline": "Health insurers had a tough year. What's ahead for 2025?",
    "summary": "Health insurers have faced significant headwinds in 2024. Yahoo Finance Health Reporter Anjalee Khemlani examines the key challenges facing the sector, including declining profits and FTC regulatory scrutiny, while analyzing the industry's outlook for 2025. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith",
    "url": "https://finnhub.io/api/news?id=cef9357efe5be00cbe1cd39fc4cfc6e6b8f36def2f002b92642cc9d6688ff235",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734731835,
      "headline": "Health insurers had a tough year. What's ahead for 2025?",
      "id": 132081411,
      "image": "https://s.yimg.com/ny/api/res/1.2/OymtZMfAb_lHq2a9WOkH1Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2024-12/6c6af7b0-bf16-11ef-bc6f-fefc9960d430",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Health insurers have faced significant headwinds in 2024. Yahoo Finance Health Reporter Anjalee Khemlani examines the key challenges facing the sector, including declining profits and FTC regulatory scrutiny, while analyzing the industry's outlook for 2025. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith",
      "url": "https://finnhub.io/api/news?id=cef9357efe5be00cbe1cd39fc4cfc6e6b8f36def2f002b92642cc9d6688ff235"
    }
  },
  {
    "ts": null,
    "headline": "Elevance Health Stock Plunges 29.6% in Q4: Buy, Hold or Sell?",
    "summary": "ELV is reallocating resources to more profitable areas and making prudent acquisitions.",
    "url": "https://finnhub.io/api/news?id=dcfa5ac1ec9d2c01630f6c9b1bcb4ea03774ab523da8339b53559fa96457863b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734724800,
      "headline": "Elevance Health Stock Plunges 29.6% in Q4: Buy, Hold or Sell?",
      "id": 132080133,
      "image": "https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "ELV is reallocating resources to more profitable areas and making prudent acquisitions.",
      "url": "https://finnhub.io/api/news?id=dcfa5ac1ec9d2c01630f6c9b1bcb4ea03774ab523da8339b53559fa96457863b"
    }
  },
  {
    "ts": null,
    "headline": "Elevance Health Inc. stock underperforms Friday when compared to competitors",
    "summary": "Elevance Health Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=733bce81ecf3bbac52a8b0f7a2052d8f4bf87d9f4efe68faa898d6c775af8fea",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734713040,
      "headline": "Elevance Health Inc. stock underperforms Friday when compared to competitors",
      "id": 132149589,
      "image": "",
      "related": "ELV",
      "source": "MarketWatch",
      "summary": "Elevance Health Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=733bce81ecf3bbac52a8b0f7a2052d8f4bf87d9f4efe68faa898d6c775af8fea"
    }
  }
]